NCT02398110

Brief Summary

Recent reports have suggested that transvaginal NOTES nephrectomy is feasible, yet comparative studies are lacking. The aim of this study was to compare the surgical outcomes of transvaginal NOTES nephrectomy to conventional laparoscopic nephrectomy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2015

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

March 10, 2015

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 25, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

August 13, 2015

Status Verified

August 1, 2015

Enrollment Period

1.5 years

First QC Date

March 10, 2015

Last Update Submit

August 10, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intensity of pain in motion (Pain Scores on the Visual Analog Scale (0-10)

    Pain Scores on the Visual Analog Scale (0-10)

    at postoperative day 1

Secondary Outcomes (6)

  • Cosmetic assessment (Patient Scar Assessment Questionnaire)

    > 3 months after surgery

  • Sexual function (Female Sexual Function Index)

    Preoperatively, and 4, 8 and 12 months postoperatively

  • Intraoperative complications (e.g. bleeding, organ-injury)

    Evaluated at the operation day

  • Duration of the operation

    at the operation day

  • Quality of life (SF-36)

    on postoperative month 1

  • +1 more secondary outcomes

Study Arms (2)

transvaginal NOTES nephrectomy

EXPERIMENTAL

A 5- and 10-mm trocar were placed at the right and left medial margin of umbilicus. A lengthened 10-mm trocar was placed through the vagina into the abdominal cavity

Procedure: transvaginal NOTES nephrectomyProcedure: conventional laparoscopic nephrectomy

conventional laparoscopic nephrectomy

ACTIVE COMPARATOR

One 10-mm trocar was inserted at the midclavicular line 2 cm below the umbilicus, another 10-mm periumbilical trocar was placed for the camera, and a 5- or 10-mm trocar was placed 3 cm below the costal margin

Procedure: transvaginal NOTES nephrectomyProcedure: conventional laparoscopic nephrectomy

Interventions

A 5- and 10-mm trocar were placed at the right and left medial margin of umbilicus. A lengthened 10-mm trocar was placed through the vagina into the abdominal cavity

conventional laparoscopic nephrectomytransvaginal NOTES nephrectomy

One 10-mm trocar was inserted at the midclavicular line 2 cm below the umbilicus, another 10-mm periumbilical trocar was placed for the camera, and a 5- or 10-mm trocar was placed 3 cm below the costal margin

conventional laparoscopic nephrectomytransvaginal NOTES nephrectomy

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • female sex,
  • indication for nephrectomy due to benign or malignant kidney disease,
  • age between 18 and 65 years, and
  • legal competence

You may not qualify if:

  • emergency surgery,
  • contraindications to laparoscopic surgery,
  • class IV or V as defined by the American Society for Anesthesiologists (ASA),
  • body mass index (BMI) of \> 30 kg/m2,
  • advanced TNM staging (≥ T3),
  • history of major abdominal surgery,
  • gravidity or breast-feeding, and
  • no written informed consent signed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Affiliated Hospital of Gannan Medical University

Ganzhou, Jiangxi, 341000, China

RECRUITING

MeSH Terms

Conditions

Kidney Diseases

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Central Study Contacts

Xiaofeng Zou, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

March 10, 2015

First Posted

March 25, 2015

Study Start

March 1, 2015

Primary Completion

September 1, 2016

Study Completion

November 1, 2016

Last Updated

August 13, 2015

Record last verified: 2015-08

Locations